Andrew Cohen

Chain Bridge I (NASDAQ:CBRG) announced on Monday the acquisition of Phytanix Bio, a pharmaceutical company specializing in the development of therapeutics based on cannabinoid and cannabinoid-like molecules. The transaction, valued at $58 million, also includes the assumption of preferred stock and...

The trial of Sam Bankman-Fried, the controversial co-founder of the now-defunct crypto exchange FTX (CRYPTO: FTT), is underway with the initial phase of juror selection and assessment. This process, overseen by U.S. District Judge Lewis Kaplan, continued into its second day after some...